TRIP11
Basic information
Region (hg38): 14:91965991-92040896
Links
Phenotypes
GenCC
Source:
- achondrogenesis type IA (Definitive), mode of inheritance: AR
- achondrogenesis type IA (Strong), mode of inheritance: AR
- achondrogenesis type IA (Supportive), mode of inheritance: AR
- achondrogenesis type IA (Moderate), mode of inheritance: AR
- achondrogenesis type IA (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Achondrogenesis, type IA; Odontochondrodysplasia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dental; Musculoskeletal; Pulmonary; Renal | 4885523; 7460382; 3275766; 18241073; 20089971; 30728324 |
ClinVar
This is a list of variants' phenotypes submitted to
- Achondrogenesis, type IA (38 variants)
- Odontochondrodysplasia 1 (3 variants)
- not provided (2 variants)
- Connective tissue disorder (1 variants)
- TRIP11-related disorder (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIP11 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 119 | 136 | ||||
missense | 288 | 17 | 14 | 322 | ||
nonsense | 18 | 23 | ||||
start loss | 0 | |||||
frameshift | 23 | 28 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 9 | 10 | 3 | 22 | ||
non coding | 43 | 107 | 81 | 232 | ||
Total | 43 | 19 | 345 | 244 | 104 |
Highest pathogenic variant AF is 0.0000197
Variants in TRIP11
This is a list of pathogenic ClinVar variants found in the TRIP11 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-91967929-C-T | Achondrogenesis, type IA | Benign (Jan 12, 2018) | ||
14-91968082-C-A | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968119-A-T | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91968152-C-T | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91968299-T-G | Achondrogenesis, type IA | Benign (Jan 12, 2018) | ||
14-91968333-AT-A | Achondrogenesis | Uncertain significance (Jun 14, 2016) | ||
14-91968333-A-AT | Achondrogenesis | Likely benign (Jun 14, 2016) | ||
14-91968379-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968461-G-A | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968479-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91968488-C-T | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968498-G-C | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91968613-G-A | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91968721-T-A | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91968735-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91968743-G-A | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91968769-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968782-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968833-T-C | Achondrogenesis, type IA | Uncertain significance (Jan 12, 2018) | ||
14-91968924-C-T | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91969009-G-A | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91969045-G-A | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91969063-T-G | Achondrogenesis, type IA | Benign (Jan 13, 2018) | ||
14-91969129-G-A | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) | ||
14-91969182-T-G | Achondrogenesis, type IA | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIP11 | protein_coding | protein_coding | ENST00000267622 | 21 | 74906 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.71e-12 | 1.00 | 125562 | 0 | 186 | 125748 | 0.000740 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.515 | 903 | 948 | 0.953 | 0.0000464 | 13129 |
Missense in Polyphen | 230 | 270.47 | 0.85036 | 4021 | ||
Synonymous | -0.886 | 367 | 346 | 1.06 | 0.0000175 | 3506 |
Loss of Function | 5.72 | 39 | 101 | 0.386 | 0.00000554 | 1259 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000870 | 0.000869 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000436 | 0.000435 |
Finnish | 0.00157 | 0.00157 |
European (Non-Finnish) | 0.000901 | 0.000888 |
Middle Eastern | 0.000436 | 0.000435 |
South Asian | 0.000532 | 0.000523 |
Other | 0.000819 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Binds the ligand binding domain of the thyroid receptor (THRB) in the presence of triiodothyronine and enhances THRB- modulated transcription. Golgi auto-antigen; probably involved in maintaining cis-Golgi structure. {ECO:0000269|PubMed:10189370, ECO:0000269|PubMed:9256431}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving TRIP11 may be a cause of acute myelogenous leukemia. Translocation t(5;14)(q33;q32) with PDGFRB. The fusion protein may be involved in clonal evolution of leukemia and eosinophilia. {ECO:0000269|PubMed:9373237}.; DISEASE: Achondrogenesis 1A (ACG1A) [MIM:200600]: A form of achondrogenesis type 1, a lethal form of chondrodysplasia characterized by deficient ossification in the lumbar vertebrae and absent ossification in the sacral, pubic and ischial bones and clinically by stillbirth or early death. In addition to severe micromelia, there is a disproportionately large cranium due to marked edema of soft tissues. {ECO:0000269|PubMed:20089971}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Intraflagellar transport;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.900
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.61
Haploinsufficiency Scores
- pHI
- 0.194
- hipred
- Y
- hipred_score
- 0.590
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.805
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Trip11
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype;
Gene ontology
- Biological process
- ventricular septum development;chondrocyte differentiation involved in endochondral bone morphogenesis;transcription by RNA polymerase II;protein glycosylation;Golgi organization;intraciliary transport involved in cilium assembly;inner ear receptor cell stereocilium organization;positive regulation of nucleic acid-templated transcription
- Cellular component
- Golgi membrane;inner acrosomal membrane;outer acrosomal membrane;nucleus;Golgi apparatus;cis-Golgi network;cytoskeleton;cilium;nuclear speck;transport vesicle
- Molecular function
- transcription coactivator activity;protein binding